Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 809 results for "edwards lifesciences"

BNP Paribas Arbitrage SA Has $975,000 Stake in Edwards Lifesciences Corp. (EW)
WKRB News

BNP Paribas Arbitrage SA Has $975,000 Stake in Edwards Lifesci...

BNP Paribas Arbitrage SA lowered its stake in Edwards Lifesciences Corp. (NYSE:EW) by 56.2% during the third quarter, Holdings Channel reports. The firm owned 8,084 shares of the medical research company's stock after selling 10,360 shares during ... WKRB News, 9 hours ago
[x]  

168 images for edwards lifesciences

American Banking News, 1 day ago
PR Newswire, 2 days ago
WKRB News, 9 hours ago
WKRB News, 3 days ago
WorldNetDaily, 2 days ago
Yahoo! Singapore, 2 days ago
American Banking News, 2 days ago
prnewswire.com, 2 days ago
MassDevice, 2 days ago
Investor's Business Daily, 2 days ago

Edwards Lifesciences Paints A Picture Of A Compelling Future

Following Edwards Lifesciences Corp (NYSE: EW )'s investor conference, analysts were upbeat about the company's prospects. Here are the opinions offered by sell-side analysts. Net-Net Positive Premised on the better-than-expected 2017 ...
 Benzinga.com1 day ago

U.S. Health Care Under a Trump Presidency

Michael Mussallem, chairman and chief executive officer at Edwards Lifesciences, discusses the future of Obamacare, expectations for health care policy under President-elect Donald Trump, and the growth of his company's business. He speaks with ...
 Bloomberg1 day ago

BRIEF-Edwards Lifesciences sees 2017 global sales of $3.0 bln to $3.4 bln

n"Dec 8 Edwards Lifesciences Corp : * Sees 2017 global sales of $3.0 billion to $3.4 billion; sees 2017 adjusted earnings per share $3.30 to $3.45 * Q4 sales are trending towards lower end of guidance * Sees 2017 Transcatheter Heart Valve Therapy ...
 Reuters UK2 days ago Edwards Lifesciences sees 2017 top-line up as much as 14% with non-GAAP EPS of $3.30 - 3.45  Seeking Alpha2 days ago
Benzinga.com

VALTECH : Cardio, Ltd. Agrees to be Acquired by Edwards Lifesciences

By a News Reporter-Staff News Editor at Cardiovascular Week -- - HYPERLINK "http://www.valtechcardio.com/" nValtech Cardio, Ltd., (Valtech), an innovator in the field of device development for mitral and tricuspid valve repair and replacement, ...
 4 Traders2 days ago Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference  TickerTech.com2 days ago EDWARDS LIFESCIENCES : Outlines Growth Strategy At Annual Investor Conference  4 Traders2 days ago Edwards buys Israeli co Valtech Cardio for $1b  Globes1 week ago
[x]  

Edwards Gets Everything But The Valve

Edwards Lifesciences (NYSE: EW ) has bought a mitral valve company but not the mitral valve. The Irvine, California-based group has acquired Valtech Cardio for $340m up front, but Valtech's Cardiovalve transcatheter mitral valve replacement device ...
 Seeking Alpha1 week ago Edwards makes another big acquisition in the transcatheter mitral valve space, this time for $690M  MedCity News1 week ago

Edward Lifesciences - Structural Growth Play Starts To Look Appealing, Inititating On Further Dips

Edward Lifesciences ( EW ) is a very impressive business, being a true leader in tackling structural heart diseases with its valves portfolio, notably the SAPIEN 3. The company has reported impressive growth in the past, and is actually delivering ...
 Seeking Alpha1 week ago

Edwards To Buy Valtech Cardio For $340 Mln; Approves New $1 Bln Share Buyback

Medical technology company Edwards Lifesciences Corp. (EW) announced Monday that it has agreed to acquire Israel-based Valtech Cardio Ltd. The purchase price is $340 million in stock and cash at closing, with the potential for up to $350 million ...
 RTTNews.com1 week ago
ACQ Magazine

RSI Alert: Edwards Lifesciences (EW) Now Oversold

 Forbes.com2 weeks ago
[x]  

Jim Cramer Gives His Opinion On Opko Health, Edwards Lifesciences And GW Pharma

On CNBC's Mad Money , Jim Cramer spoke about Opko Health Inc. (NASDAQ: OPK ). He has faith in its CEO, Phillip Frost, and he wants to take a long-term view in the stock. Opko Health spiked 9.84 percent on Monday. Cramer explained that Edwards ...
 Benzinga.com3 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less